- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03916016
Sí Texas Hope Family Health Center
April 18, 2019 updated by: Karen Errichetti, Health Resources in Action, Inc.
Sí Texas HOPE: Enhanced Integrated Behavioral Health Model for Uninsured Patients
This study evaluated whether uninsured patients living at or below 200% of the federal poverty level who received enhanced, culturally-relevant, integrated behavioral health services were more likely to improve health outcomes after 12 months compared to similar patients receiving usual care from Hope Family Health Center (HFHC), a charitable community clinic.
The study employed a randomized control trial (RCT) design where intervention participants receiving integrated care at HFHC were compared to control participants receiving usual care at HFHC.
Patients were placed in each group using simple random assignment.
Demographic and health outcome data were collected from intervention and control participants at baseline.
Health outcome data were subsequently collected at 6-month and 12-month follow-up points.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This study evaluated whether uninsured patients living at or below 200% of the federal poverty level who received enhanced, culturally-relevant, integrated behavioral health services were more likely to improve health outcomes after 12 months compared to similar patients receiving usual care from Hope Family Health Center (HFHC), a charitable community clinic.
The study employed a randomized control trial (RCT) design where intervention participants receiving integrated care at HFHC were compared to control participants receiving usual care at HFHC.
Patients were placed in each group using simple random assignment.
Demographic and health outcome data were collected from intervention and control participants at baseline.
Health outcome data were subsequently collected at 6-month and 12-month follow-up points.
The primary outcomes of interest were systolic and diastolic blood pressure and depressive symptoms.
Additional secondary outcomes of interest were HbA1c and BMI.
These outcomes were analyzed as continuous variables using linear regression with backward model selection.
Longitudinal analyses were also conducted using a likelihood-based approach to general linear mixed models.
The participants (1) resided in Cameron, Hidalgo, Willacy, or Starr County, (2) were eligible to receive behavioral health services from HFHC (e.g., uninsured, living at or below 200% of the federal poverty level, residence in HFHC's service area), and (3) had a diagnosis of hypertension (blood pressure of 140/90 mm Hg or higher) and/or obesity (body mass index of 30.0 or higher) and/or poorly controlled diabetes (HbA1c over 6.8) and/or moderate depression (score of 10 or above on PHQ-9).
Study Type
Interventional
Enrollment (Actual)
585
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Reside in Cameron, Hidalgo, Starr, or Willacy County
- Were eligible to receive behavioral health services from HFHC (e.g., uninsured, living at or below 200% of the federal poverty level, residence in HFHC's service area)
- Have a diagnosis of one or more chronic conditions:
- Hypertension (blood pressure of 140/90 mmHg or higher)
- Obesity (body mass index of 30.0 or higher)
- Poorly controlled diabetes (HbA1c over 6.8%)
- Moderate depression (score of 10 or above on PHQ-9)
Exclusion Criteria:
- Not actively suicidal at time of enrollment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Group
The intervention group received enhanced integrated behavioral health care.
|
The intervention involved moving from HFHC's previous collaborative model, where medical and behavioral providers worked with each other episodically, to a more fully integrated collaborative care model with care coordination, shared treatment plans, shared service provision, and shared record keeping.
To achieve this enhanced level of integration, HFHC changed its current primary care workflow to include a behavioral health specialist who conducted assessments, provided initial counseling (individual or group), and coordinated referrals to care management and/or community-based health services.
|
Active Comparator: Control Group
The control group received care as usual only.
|
A collaborative model where medical and behavioral providers worked with each other episodically
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood Pressure
Time Frame: One year
|
Blood pressure was measured as a continuous variable (systolic and diastolic) in millimeters of mercury (mmHg).
|
One year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body mass index
Time Frame: One year
|
Height and weight were measured at baseline, and body mass index was calculated.
|
One year
|
Depressive Symptoms
Time Frame: One year
|
Score calculated based on responses to the Patient Health Questionnaire-9.
The PHQ-9 has a total possible score of 27.
Each of the nine questions is assigned a value of 0, 1, 2, or 3.
The total score is the sum of individual questions' scores.
The PHQ-9 scoring criteria is categorized as minimal (0-4), mild (5-9), moderate (10-14), moderately severe (15-19) and severe (20-27) depression.
|
One year
|
Blood glucose concentration
Time Frame: One year
|
Blood glucose concentration was measured via blood test for HbA1c as a continuous variable
|
One year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 9, 2015
Primary Completion (Actual)
March 29, 2018
Study Completion (Actual)
March 29, 2018
Study Registration Dates
First Submitted
April 12, 2019
First Submitted That Met QC Criteria
April 12, 2019
First Posted (Actual)
April 16, 2019
Study Record Updates
Last Update Posted (Actual)
April 22, 2019
Last Update Submitted That Met QC Criteria
April 18, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 100002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Lawson Health Research InstituteTerminated
Clinical Trials on Enhanced Integrated Behavioral Health Care
-
San Diego State UniversityRecruitingType 2 Diabetes | Psychological Distress | Glycemic ControlUnited States
-
East Carolina UniversityBristol-Myers SquibbCompletedDepression | Type 2 Diabetes Mellitus | Diabetes-related DistressUnited States
-
Scott & White Health PlanCompletedChronic IllnessUnited States
-
Vardalinstitutet The Swedish Institute for Health...VinnVårdCompleted
-
Peking University Third HospitalRecruitingHyperlipidemia | Cardiometabolic DiseaseChina
-
Atlanta VA Medical CenterUniversity of California, Los Angeles; University of Alabama at Birmingham; Emory... and other collaboratorsRecruitingInsomnia | NocturiaUnited States
-
The First Affiliated Hospital with Nanjing Medical...University of LiverpoolActive, not recruitingStroke | Atrial Fibrillation | OlderChina
-
Him SACompletedHeart Failure | Stroke | Diabetes | COPD
-
Kaohsiung Medical University Chung-Ho Memorial...UnknownStable Angina | Acute Myocardial InfarctionTaiwan
-
International Maternal Pediatric Adolescent AIDS...National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsCompletedDepression | HIVUnited States